is...optimistic for the future of CNS conditions thanks to Anavex Life Sciences.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same.
"Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment."
The featured analysts have either purposefully chosen to ignore Anavex Life Sciences, or they are guilty of not performing their due diligence regarding the sector.
https://www.reuters.com/world/asia-pacific/hundreds-thai-medical-workers-infected-despite-sinovac-vaccinations-2021-07-11/
Chinese vaccine technology is crap.
Seeking Alpo needed some clickbait apparently.
"Chinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says"
Not good enough.
It's Novavax time!
Time to drop a hammer on Biogen and their FDA manipulation.
https://www.washingtonpost.com/health/2021/07/09/aduhelm-new-alzheimers-drug-hhs-inspector-general/
Anavex stands to inherit a solid chunk of the market.
https://www.wsj.com/video/delta-variant-likely-to-spread-world-wide/947FBCE7-8A78-4839-8137-6800B6CFD778.html?mod=trending_now_video_3
Better have a better therapeutic ready!
Brilacidin or bust.
Some supplemental reading to that...
https://www.movementdisorders.org/MDS-Files1/PDFs/Task-Force-Papers/unified.pdf
Anavex is crushing it!
https://ir.novavax.com/2021-06-30-Novavax-Statement-on-Proof-of-Vaccination-for-Phase-3-Clinical-Trial-Participant
AVXL is a BU (Build Up), not a BO (Buyout) company.
Given the patents, compounds, results, indications, and financing, Anavex Life Sciences is the company breaking the entrenched amyloid status quo sinkholes.
Disruptive technology (2-73, 3-71, and biomarker tracing) for the win!
The doubters, haters, and the fearful big pharmas are in a tizzy.
"The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better"
https://www.theatlantic.com/health/archive/2021/06/novavax-now-best-covid-19-vaccine/619276/
"Persistent hype around mRNA vaccine technology is now distracting us from other ways to end the pandemic."
We'll have our NVAX parallel with AVXL.
Blarcamesine and 3-71 are going to be the big hitters in the decade ahead.
This offering will be snatched up in a matter of hours. Easy peasy shorty squeezy!
None of those amyloid-focused big pharmas seems to have the integrity to place truth before lives at risk.
Fortunately Anavex chose to focus UPSTREAM.
More time to accumulate.
Would be good to know more about Brilacidin's antifungal potential too!
https://www.sciencenews.org/article/coronavirus-covid-deadly-black-fungus-infection-india
Ours is a global, interconnected world.
Chinese vaccine is insufficient. Oops.
https://www.yahoo.com/news/relied-chinese-vaccines-now-theyre-182246542.html
Better get the REAL deal! Novavax for the world.
Indeed...
And with even greater potential.
https://www.nature.com/articles/d41586-021-01359-3
https://www.scientificamerican.com/article/mix-and-match-covid-vaccines-trigger-potent-immune-response/
https://www.dw.com/en/mix-and-match-vaccines-biontech-astrazeneca-better-than-one-shot/a-57819127
The sooner it is added to the arsenal the better!
https://www.scientificamerican.com/article/coronavirus-news-roundup-june-5-to-june-18/
"Novavax reports that its two-dose protein-based vaccine against COVID-19 has been 100% effective in preventing severe illness, hospitalization and death due to COVID-19, as well as 90.4% effective against COVID-19 symptoms in large-scale human studies. These studies, which involved thousands of people in the U.S. and Mexico, showed that the vaccine also was highly effective against “Alpha,” the SARS-CoV-2 variant first identified in Great Britain, reports Carl Zimmer at The New York Times (6/14/21). “Novavax plans to apply for authorization in UK, EU, India, South Korea, and possibly the U.S.,” according to an Unbiased SciPod post (6/15/21)."
Novavax’s Covid Vaccine Is Real Competition for Pfizer and Moderna
https://www.barrons.com/articles/novavax-covid-vaccine-pfizer-moderna-51623691547
I WANT THIS SHOT!
COVID-19 vaccine candidate efficacy in those 18 to <65 years old was preserved in influenza vaccine recipients
- Influenza vaccine immunogenicity preserved
- Study demonstrated no early safety concerns
- Data available ahead of publication via preprint server, medRxiv
http://ir.novavax.com/news-releases/news-release-details/novavax-announces-positive-results-first-study-influenza-vaccine
We'll be calling it Done-Pez-Zilch.
Blarcamesine and 3-71 will leave that old drug in the dust.
New standard of care by Anavex.
A heroic push to the close or AH in the $25+ ballpark would be a fitting Monday's end.
Ought to be a good couple months ahead.
They'll have to pay the BIG bucks if they want 2-73 and 3-71.
Up 600%...and I ain't sellin' yet.
AVXL has some of the greatest potential for good, along with Brilacidin.
Patience...
That'd be a nice watermark, but it should be MUCH higher.
Nice! Broader exposure. Should be a very positive development.
The classic one of Jim Cramer divulging short FUD attacks.
Debate at 1 am?
"management’s explanation"?!
Are you trying to gaslight the BS Rosen attack on CTIX?
https://casetext.com/case/zagami-v-cellceutix-corp-1
Abusive litigation indeed, and nothing short of shorts (when IPIX was CTIX and still listed on an exchange) with their filthy fingers in the pudding.
If Leo follows the spirit and the letter and adheres to proper guidance, then the eventual payoff is huge.
Patience is the key here. No jumping of the gun. No BS. Allow the primary investigators to do their jobs.
This is the big one. Brilacidin for the win.
Even boosters for vaccines have limitations, especially with variants sprouting up.
Brilacidin (defensin mimetic) as a possible treatment that disrupts viruses, bacteria, and fungi would be the answer to not only COVID and variants, but entire swaths of disease.
HDMPs are not simply one trick ponies. Their pluripotentiality is disruptive technology.
https://www.precisionvaccinations.com/vaccines/brilacidin-covid-19-therapeutic
https://clinicaltrials.gov/ct2/show/NCT04784897?term=brilacidin&draw=2&rank=2
What happens when the 'adookienub' patients have hemorrhages?
https://www.nytimes.com/2021/06/05/health/alzheimers-aducanumab-fda.html
No thanks! 100% behind blarcamesine and 3-71.
Wondering how long it will be until people are dying...
https://www.washingtonpost.com/health/2021/06/07/fda-approves-alzheimers-drug-aducanumab/?itid=hp-top-table-main
"The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives the U.S. preferential orders for the COVID-19 vaccines developed by AstraZeneca , Novavax Inc. , and Sanofi . None of these shots have been authorized in the U.S., but the change allows the companies to decide which orders, including from other countries, they will fulfill first."
Neural pathways to the future with Anavex.
Just gets better and better.
Mitochondria function better...with blarcamesine.
(It'll be exciting to see 3-71's efficacy in addition to 2-73.)
Was wondering whether any Russian oligarchs have observers in the clinics.
Positive results would get people excited and talking in a hurry.
Good news has a way of getting out, especially in life-or-death matters.
Outstanding.
Solid goodness on display!